Control tower for contact centers that uses EEG headsets to prevent agent burnout and lift QA in real time.

1. Licensing makes EEG hardware distribution broader and faster than a single-device strategy, opening room for software partners.
2. Neurable is explicitly taking BCI beyond research into everyday consumer wearables, reducing the need for a startup to build custom hardware first.
3. Real-time biofeedback and daily cognitive reports already exist in a live product, so buyers can imagine concrete focus and burnout workflows today.
4. The market shift creates an application-layer opening: OEMs can ship sensors, but operators still need trusted workflow software for interventions and ROI proof.

Catalyst. Neurable's licensing push and live focus-burnout product prove EEG wearables are moving from research devices into deployable everyday hardware, making an application-layer ops product newly feasible now.

Cognitive Fatigue Ops plugs into EEG-enabled headsets from OEM partners that license Neurable-like technology and converts raw brain-signal streams into calibrated fatigue, focus, and recovery scores for each shift. The product feeds those scores into workforce-management workflows to suggest microbreak timing, route lower-complexity calls when overload rises, and surface coaching moments to supervisors. It also gives operators an auditable dashboard showing which interventions improved QA, handle time, and attrition risk. Employees see their own trend data and consent settings so the product can be deployed as a performance and burnout-prevention tool rather than covert surveillance.

What's different. This is not another wellness app or generic biosignal dashboard. The company wins by specializing in one workflow where workers already wear audio hardware all day, where fatigue has direct unit economics, and where intervention actions are clear. Over time it builds a hard-to-replicate dataset linking cognitive states, staffing actions, and business outcomes across thousands of shifts, which improves recommendations and makes it the default operating layer for OEM-delivered EEG wearables.

Jobs to be done

flowchart LR
  Buyer[Contact center ops leader] --> Pain[Invisible agent fatigue and burnout]
  Pain --> Product[EEG fatigue ops layer]
  Product --> Outcome[Higher QA lower attrition]

Executive takeaways

• Neurable's licensing move makes this a software-distribution timing bet, not a custom-hardware bet. [1][2][3]
• The pain is real: large BPOs still manage massive labor pools and disclose attrition pressure, so earlier intervention can matter economically. [4][5][6]
• Budget adjacency exists because contact-center teams already buy WFM, QA, and AI-assist tooling; this does not require a brand-new wellness budget. [18][19][20][21][29]
• Regulation is the main gating risk: workplace AI, biometric, and health-data scrutiny can block deployment if the product looks like surveillance. [7][7][9][10][12][12][13][13]
• The real competitors are workflow incumbents such as NICE, Observe.AI, Cresta, and MaestroQA, not only other BCI vendors. [19][20][21][22][29]
• Near-term scope must stay low-risk—microbreaks, queue routing, coaching prompts—because consumer EEG is improving but still noisy in real work conditions. [3][22][25][26][27][28]
• Modeled year-3 SOM is about $1.8M ARR, which is credible for a partner-meeting discussion but small enough that later category expansion is mandatory. [18][21]

Market definition

The relevant market is workflow software that turns non-invasive EEG telemetry from everyday wearables into auditable operational interventions for outsourced contact-center teams. The buyer is an operations or workforce-management leader. Adjacent markets include telesales, telehealth, dispatch, and other headset-heavy workflows; excluded are implants, generic wellness apps, and broad employee-monitoring suites without a narrow intervention loop. [1][2][3][15][16][17]

Customer and buyer

The best early customer is a 500+ seat outsourced support operation with standardized headsets, measurable QA pressure, and visible attrition. The economic buyer is the VP Operations or Head of Workforce Management; users are WFM, QA, and site leaders. Current substitutes are WFM suites, QA tools, supervisor judgment, and periodic wellness surveys. [4][5][6][18][19][20][21][29]

Buying triggers

• A headset refresh or OEM bundle makes EEG deployment newly plausible. [1][2][3]
• Burnout, QA variance, or staffing pressure pushes ops leaders to seek another intervention lever. [5][6][24]
• BPO-governance initiatives create demand for more explainable interventions across sites and vendors. [21]

Willingness to pay

Assembled publicly lists workforce management from $25/month and AI copilot from $35/month, while Neurable packages brain-health value into a $499 device. That supports a seat-based add-on positioned below core WFM / copilot spend. [3][18] [3][18]

Category dynamics

Growth signal 23.21% CAGR in contact-center software (2026-2035)

Validation signals

• Neurable is licensing its technology to more wearables makers.
• Neurable already markets focus, burnout, and daily cognitive insights in a mainstream device.
• Assembled publicly prices adjacent support-ops tooling.
• Observe.AI, Cresta, and MaestroQA all sell operational decision-support products to the same buyer.
• TTEC and TaskUs still treat workforce stability as economically important.

Regulatory & technical constraints

• EU workplace AI rules materially raise risk for emotion-recognition style use cases.
• Worker-health monitoring and biometrics require strong necessity and governance.
• US privacy and health-data obligations mean brain-signal data must be treated as highly sensitive.
• Labor and employment regulators are skeptical of hidden automated-management systems.
• Signal reliability still depends on calibration and conservative product claims.

Neurable and EMOTIV make the sensing layer more available, but the strategic fight is against contact-center workflow incumbents. NICE owns WFM distribution, Observe.AI owns analytics and triggers, Cresta owns agent guidance, and MaestroQA owns BPO governance. The startup wins only if neural data produces earlier or otherwise unavailable interventions and plugs into those systems. [1][19][20][21][22][29]

Why incumbents do not win by default

• BCI hardware and SDK vendors. They supply sensors and APIs, but not the contact-center ROI, intervention logic, or labor-safe policy layer.
• Contact-center suites. NICE already owns workflow and distribution, but it does not automatically own a differentiated neural signal or cross-OEM calibration layer.
• Conversation-intelligence AI vendors. Observe.AI, Cresta, and MaestroQA optimize calls and QA, yet they still reason mostly from conversations and workflows rather than physiological readiness.
• Manual and in-house ops stacks. Managers can keep using existing WFM and QA dashboards unless pilots prove neural telemetry changes outcomes materially.

Cognitive Fatigue Ops sells a workflow layer for outsourced contact centers that converts EEG telemetry from OEM headsets into low-risk staffing and coaching actions. The first customer is a US-led or other English-language BPO with 500+ voice seats, standardized over-ear headsets, and visible QA or attrition pressure. The initial product does not claim clinical inference or automated discipline; it recommends microbreaks, queue rebalancing, and supervisor prompts tied to measurable operational outcomes. This wedge is timed to Neurable's licensing push, which suggests EEG distribution may expand faster through headset OEMs than through a startup building hardware itself. The market appears real but narrow in the first three years, with research estimating about $88.8M TAM, $18.0M SAM, and $1.8M year-3 SOM for the contact-center beachhead. The company therefore has to prove two things quickly: that workers and legal teams will consent to non-disciplinary EEG monitoring, and that fatigue signals improve intervention timing beyond existing WFM and QA proxies. The plan deliberately avoids Europe, generic employee surveillance, and broad wellness software until consent, ROI, and data-rights evidence are stronger. Current evidence supports a serious watch case, but not yet a high-conviction meet, because real-world signal reliability, buyer adoption, and OEM data rights remain unproven.

Problem

• Contact-center operators usually detect burnout only after QA scores, compliance errors, or attrition worsen.
• Existing substitutes such as static break schedules, supervisor judgment, WFM dashboards, and wellness surveys do not capture in-shift cognitive overload.
• As EEG moves into everyday headsets, buyers still lack an auditable workflow product that turns brain-signal data into safe operational actions.

Solution

• Ingest EEG telemetry from licensed OEM headsets, calibrate each agent baseline, and produce fatigue, focus, and recovery scores at shift level.
• Feed those scores into supervisor and WFM workflows to recommend microbreaks, lower-complexity queue routing, and targeted coaching before performance degrades.
• Give employees visible consent controls and personal trend views, while logging every intervention and outcome so customers can prove the system is preventive rather than covert surveillance.

Why we win

• The company is not selling hardware or a generic wellness app; it is solving one workflow where workers already wear headsets and fatigue has direct unit economics.
• The product lands as an overlay on existing WFM, QA, and headset stacks, which lowers switching cost versus asking BPOs to replace core systems.
• If pilots work, the company compounds a hard-to-replicate dataset linking cross-device EEG signals, interventions, and QA or attrition outcomes across thousands of shifts.

Milestones

flowchart LR
  Wedge[Contact-center fatigue wedge] --> MVP[Consent plus scoring plus recommendations]
  MVP --> Proof[Paid pilots with QA and burnout proof]
  Proof --> Expansion[Multi-site rollout and adjacent workflows]

Founding team

Experiment roadmap

Risk assessment

What must be true

• At least 3 of the first 10 target BPOs say burnout or QA variance is urgent enough to fund a paid pilot this year.
• At least 2 OEM or headset partners allow enterprise access to the data required for production scoring and audit logs.
• In a 90-day pilot, EEG-derived recommendations outperform existing WFM or QA proxies on at least one agreed intervention metric.
• More than half of eligible agents opt in when the product is explicitly non-disciplinary and employee-visible.
• At least 1 pilot converts to production at or above the target seat-pricing band within 6 months of go-live.

Open diligence questions

• Which headset OEMs will grant enterprise data rights and support BPO deployments rather than only consumer app bundles?
• What exact KPI improvement will a VP Operations use to approve production budget after a pilot?
• How do labor, HR, and legal stakeholders define an acceptable boundary between burnout prevention and surveillance?
• How much incremental lift does EEG provide over existing schedule adherence, QA, sentiment, or handle-time signals?
• Which WFM and QA systems dominate the first 20 target logos, and how hard are those integrations in practice?

Model sanity

• Revenue engine. Base-case revenue comes from converting two founder-led paid pilots into production in Y1, reaching five logos by Y2, then expanding to twelve 700-seat logos by Q4Y3.
• Must go right. The model depends on OEM data-rights access and employee-consent workflows staying good enough to keep pilot-to-production conversion near the 50%+ BP target.
• Model breaks if. If sales cycles stretch to 12 months or pricing clears materially below $18 per seat, the downside case drives cash close to depletion before the next round.
• Next-round proof. The seed story is strongest once the company shows five production BPO logos, one multi-site expansion, and repeatable implementation with two OEM telemetry sources.

Scenarios

Sensitivity

flowchart LR
  TargetAccounts --> QualifiedPipeline
  QualifiedPipeline --> PaidPilots
  PaidPilots --> ProductionLogos
  ProductionLogos --> MonitoredSeats
  MonitoredSeats --> Revenue
  Revenue --> GrossProfit
  GrossProfit --> OperatingSpend
  OperatingSpend --> Cash

Flags: Two paid pilots convert in Y1 in the base case; if one slips, the cash curve worsens quickly. · Revenue per FTE remains below mature SaaS norms through Y3 because integrations, consent workflows, and implementation work stay relatively labor intensive. · Cash flow assumes EBITDA is a good proxy for cash burn; working-capital timing on pilot invoicing and annual prepay still needs validation in real contracts. · The Y3 plan still relies on OEM data-rights agreements and 50%+ employee opt-in staying feasible outside controlled pilots.

• Privacy backlash. Employees and regulators may view brain-signal monitoring as surveillance, killing adoption even if the ROI is clear. Mitigation: Start with explicit consent, employee-visible dashboards, limited retention, and policy controls that restrict use to wellness and staffing interventions rather than disciplinary actions.
• Signal reliability. Consumer EEG signals may be too noisy for high-stakes operational decisions in real-world call center environments. Mitigation: Limit recommendations to low-risk interventions such as breaks and routing, require calibration periods, and prove lift against QA and attrition before deeper workflow automation.
• Hardware dependency. If OEM rollout of EEG-enabled headsets is slower than expected, the startup could be blocked on device availability. Mitigation: Build the workflow and analytics layer to support multiple headset partners and launch with small pilots tied to refresh cycles rather than betting on one vendor.